Kawasaki disease echocardiography and ultrasound
|
Kawasaki disease Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
American Roentgen Ray Society Images of Kawasaki disease echocardiography and ultrasound |
|
Kawasaki disease echocardiography and ultrasound in the news |
|
Risk calculators and risk factors for Kawasaki disease echocardiography and ultrasound |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Dildar Hussain, MBBS [2]
Overview
There are no echocardiography/ultrasound findings associated with [disease name].
- Echocardiogram may show subtle coronary artery changes or, later, true aneurysms.
- Ultrasound may show hydrops (enlargement) of the gallbladder
There are no echocardiography/ultrasound findings associated with [disease name]. However, an echocardiography/ultrasound may be helpful in the diagnosis of complications of [disease name], which include [complication 1], [complication 2], and [complication 3].
Echocardiography/Ultrasound
AHA Recommendations for Cardiovascular Assessment for Diagnosis and Monitoring During the Acute Illness
The AHA Recommendations for Cardiovascular Assessment for Diagnosis and Monitoring During the Acute Illness are:[1]
| Class I |
| "1. Echocardiography should be performed when the diagnosis of KD is considered, but unavailability or technical limitations should not delay treatment (Class I; Level of Evidence B). |
| "2. Coronary arteries should be imaged, and quantitative assessment of luminal dimensions, normalized as Z scores adjusted for body surface, should be performed (Class I; Level of Evidence B). |
| "3. For uncomplicated patients, echocardiography should be repeated both within 1 to 2 weeks and 4 to 6 weeks after treatment (Class I; Level of Evidence B). |
| "4. For patients with important and evolving coronary artery abnormalities (Z score >2.5) detected during the acute illness, more frequent echocardiography (at least twice per
week) should be performed until luminal dimensions have stopped progressing to determine the risk for and presence of thrombosis (Class I; Level of Evidence B). |
| Class IIa |
| "1. To detect coronary artery thrombosis, it may be reasonable to perform echocardiography for patients with expanding large or giant aneurysms twice per week while dimensions are expanding rapidly and at least once weekly in the first 45 days of illness, and then
monthly until the third month after illness onset, because the failure to escalate thromboprophylaxis in time with the rapid expansion of aneurysms is a primary cause of morbidity and mortality (Class IIa; Level of Evidence C). |
References
- ↑ McCrindle, Brian W.; Rowley, Anne H.; Newburger, Jane W.; Burns, Jane C.; Bolger, Anne F.; Gewitz, Michael; Baker, Annette L.; Jackson, Mary Anne; Takahashi, Masato; Shah, Pinak B.; Kobayashi, Tohru; Wu, Mei-Hwan; Saji, Tsutomu T.; Pahl, Elfriede (2017). "Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association". Circulation. 135 (17): e927–e999. doi:10.1161/CIR.0000000000000484. ISSN 0009-7322.